{
    "clinical_study": {
        "@rank": "45246", 
        "arm_group": [
            {
                "arm_group_label": "Endoscopic treatment alone", 
                "arm_group_type": "Active Comparator", 
                "description": "3 to 5 sessions of sclerotherapy till eradication of esophageal varices."
            }, 
            {
                "arm_group_label": "Total EGDS + endoscopy", 
                "arm_group_type": "Active Comparator", 
                "description": "Esophagogastric devascularization with splenectomy followed by endoscopic sclerotherapy of esophageal varices 2 months postoperatively."
            }
        ], 
        "brief_summary": {
            "textblock": "Upper gastrointestinal bleeding (UGIB) is a major cause of morbidity and mortality in\n      patients with portal hypertension secondary to schistosomiasis mansoni. Taking into account\n      the endemic nature of schistosomiasis mansoni in our region and the high morbidity and\n      mortality directly associated with rupture of esophageal varices and UGIB in affected\n      patients, we conducted a prospective randomized trial in patients with schistosomiasis and a\n      history of bleeding esophageal varices. Its purpose was to assess the efficacy of endoscopic\n      treatment alone compared  with the efficacy of sclerotherapy preceded by a surgical\n      treatment: Esophagogastric devascularization with splenectomy (EGDS)."
        }, 
        "brief_title": "Treatment Schistosomal Portal Hypertension: Efficacy of Endoscopy or Surgery", 
        "completion_date": {
            "#text": "March 2009", 
            "@type": "Actual"
        }, 
        "condition": [
            "Schistosomiasis Mansoni", 
            "Portal Hypertension", 
            "Upper Gastrointestinal Bleeding"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Gastrointestinal Hemorrhage", 
                "Hemorrhage", 
                "Hypertension", 
                "Hypertension, Portal", 
                "Schistosomiasis", 
                "Schistosomiasis mansoni"
            ]
        }, 
        "detailed_description": {
            "textblock": "This was a prospective, randomized, single-center study carried out at the Department of\n      Clinical and Surgical Gastroenterology of Hospital Universit\u00e1rio Professor Alberto Antunes,\n      Universidade Federal de Alagoas (HU/UFAL). It was approved by the local Research Ethics\n      Committee (protocol #98/0039-3, code 4010000-6) and all patients provided written informed\n      consent prior to study enrollment. Patients who met relative criteria for exclusion received\n      the current standard of care and follow-up and were analyzed as a third group in the study.\n\n      Over a two-year period, 79 patients were recruited for elective treatment of SPH. The\n      criteria for selection were: a) an established diagnosis of hepatosplenic schistosomiasis as\n      the cause of portal hypertension; b) a history of UGIB secondary to rupture of esophageal\n      varices, with at least 20 days having elapsed since the most recent episode of bleeding; and\n      c) age between 15 and 65 years.\n\n      The exclusion criteria were: chronic alcoholism, defined as an alcohol intake of \u226560\n      g/EtOH/day in men and \u226540 g/EtOH/day in women; evidence of decompensated liver disease of\n      mixed etiology or of any chronic disease that contraindicated surgery were considered\n      absolute exclusion criteria; the relative criteria for exclusion were altered hemostasis\n      (platelet count < 50\u00d7109/L or INR > 1.5); presence of fundal varices on endoscopy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age between 15 and 65 years;\n\n          -  an established diagnosis of hepatosplenic schistosomiasis as the cause of portal\n             hypertension;\n\n          -  a history of UGIB secondary to rupture of esophageal varices, with at least 20 days\n             having elapsed since the most recent episode of bleeding.\n\n        Exclusion Criteria:\n\n          -  Chronic alcoholism, defined as an alcohol intake of \u226560 g/EtOH/day in men and \u226540\n             g/EtOH/day in women;\n\n          -  evidence of decompensated liver disease of mixed etiology or of any chronic disease\n             that contraindicated surgery were considered absolute exclusion criteria;\n\n          -  the relative criteria for exclusion were altered hemostasis (platelet count <\n             50\u00d7109/L or INR > 1.5);\n\n          -  presence of fundal varices on endoscopy."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "54", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "March 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01931826", 
            "org_study_id": "UNCISAL-2012-Treatment PHS"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Endoscopic treatment alone", 
                    "Total EGDS + endoscopy"
                ], 
                "description": "The presence of gastroesophageal varices was confirmed by fiberoptic esophagogastroduodenoscopy (EGD). In view of the experience of our service and local circumstances at the time of the study, the endoscopic treatment of choice was sclerotherapy, performed with a Teflon-sheathed metal needle. The sclerosing agent was 2.5% monoethanolamine oleate. Esophageal varices visible on EGD in the pre- and post-treatment period were classified as small, medium or large on the basis of criteria proposed by Paquet. All complications attributable to sclerotherapy were recorded.", 
                "intervention_name": "Endoscopic treatment", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Total EGDS + endoscopy", 
                "description": "Esophagogastric devascularization with splenectomy followed by endoscopic sclerotherapy of esophageal varices 2 months postoperatively.", 
                "intervention_name": "Total EGDS+ endoscopy", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Schistosomiasis", 
            "Surgical treatment", 
            "Endoscopic treatment"
        ], 
        "lastchanged_date": "August 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Maceio", 
                    "country": "Brazil", 
                    "state": "Alagoas", 
                    "zip": "57000000"
                }, 
                "name": "Universidade Federal de Alagoas"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Treatment of Schistosomal Portal Hypertension: Assessment of Efficacy of Endoscopic Therapy Alone or in the Combined With Surgical Procedure", 
        "other_outcome": {
            "measure": "No other outcomes were evaluated.", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "overall_official": {
            "affiliation": "Universidade Estadual de Ci\u00eancias da Sa\u00fade de Alagoas", 
            "last_name": "Celina Lacet, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: National Committee of Ethics in Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2005", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Its purpose was to assess the efficacy of endoscopic treatment alone compared  with the efficacy of sclerotherapy preceded by EGDS.", 
            "measure": "Sucess of treatment evaluated clinically by the absence of UGIB in the two years o follow-up.", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01931826"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universidade Estadual de Ci\u00eancias da Sa\u00fade de Alagoas", 
            "investigator_full_name": "Celina Maria Costa Lacet", 
            "investigator_title": "Doctor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Endoscopic evaluation of presence and grade of esophageal varices were made in both groups during the follow-up.", 
            "safety_issue": "Yes", 
            "time_frame": "24 months"
        }, 
        "source": "Universidade Estadual de Ci\u00eancias da Sa\u00fade de Alagoas", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universidade Estadual de Ci\u00eancias da Sa\u00fade de Alagoas", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2003", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}